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The parasite Neospora caninum is an important abortifacient agent in cattle worldwide. At present, the
development of an effective and safe vaccine against bovine neosporosis is of great relevance. Recently, a new
isolate of N. caninum (Nc-Spain 1 H) which was obtained from the brain of an asymptomatic congenitally infected
calf, exhibited non-virulent behaviour in mouse and bovine infection models. The aim of this study was to
determine the safety and efficacy of Nc-Spain 1 H when used as a vaccinal isolate in well-established BALB/c
models of congenital and cerebral neosporosis. Mice were subcutaneously immunised twice at 3-week intervals
and were challenged with 2 × 106 tachyzoites of the virulent Nc-Liv isolate. After immunisation with live Nc-Spain
1 H tachyzoites, no parasitic DNA was detected in the dams’ brains before challenge and microsatellite analysis
performed in PCR-positive mice showed that the profiles corresponded to the challenge isolate Nc-Liv, indicating
the Nc-Spain 1 H isolate to be a safe vaccine candidate. The efficacy of the live vaccine was evaluated in the first
experiment after the immunisation of mice with 5 × 105 live Nc-Spain 1 H tachyzoites. This immunisation protocol
significantly reduced the neonatal mortality to 2.4%, reduced the vertical transmission from 89.1% to 2.3% and
completely limited the cerebral infection. These results were associated with a Th1-type immune response. In the
second experiment, the effect of various immunising doses was established using ten-fold dilutions of the
tachyzoites (from 5× 105 to 5 × 10). In all the cases, congenital protection rates above 60% were observed, and the
mice that were immunised with the lowest dose (5 × 10) presented the highest protection rate (86%). Moreover,
low immunising doses of Nc-Spain 1 H induced an IgG2a response, and high parasitic doses induced an IgG1
response. These results evidence the safety and the efficient protection that was conferred by Nc-Spain 1 H against
congenital neosporosis, even when the mice were immunised with low parasitic doses.Introduction
The obligate-intracellular protozoan parasite Neospora
caninum is a major cause of reproductive failure in cattle
worldwide. Currently, no effective measures to prevent
abortion or the vertical transmission of the parasite are
available. Immunoprophylaxis has been postulated as
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distribution, and reproduction in any mediumneosporosis [1]. Live vaccines have demonstrated the
most promising results in terms of protection because
these formulations can more effectively stimulate both
humoral and cell-mediated responses [2]. However, live
vaccines may present safety problems. Several procedures
have been developed to obtain low-virulence N. caninum
strains, such as temperature-sensitive mutants, irradiated
tachyzoites and attenuated tachyzoites, through pro-
longed passage in tissue culture [3-5]. Naturally attenu-
ated isolates of N. caninum obtained from asymptomatic
infected animals have emerged in the last few years as
feasible live vaccine candidates [6-9].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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(Nc-Spain 1 H) was obtained from the brain of a congeni-
tally infected calf and was demonstrated to be an avirulent
isolate. Nc-Spain 1 H demonstrated a lower rate of multi-
plication in cell culture and a lower in vitro invasive ability
than did the Nc-1 isolate [8,10]. The pathogenicity of Nc-
Spain 1 H was examined in BALB/c mice; the results
revealed that Nc-Spain 1 H failed to induce clinical signs
of infection or mortality, and no parasites were detected
in these mice. In a pregnant mouse model, the offspring
survival rate from Nc-Spain 1 H-infected dams was almost
100%, and N. caninum was detected in only one pup [8].
Furthermore, the inoculation of Nc-Spain 1 H tachyzoites
in cattle at 70 days gestation did not induce foetal death
[11]. These data indicate that Nc-Spain 1 H may be a low-
virulence isolate and may be a suitable candidate for live-
vaccine development.
In contrast, studies regarding the influence of dose on
the protective response, which allow the optimisation of
the number of live parasites inoculated per animal, could
provide results that prove valuable to cost-efficient in-
dustrial production. Additionally, some reports have sug-
gested the importance of the antigenic dose in the
modulation of the immune response and thus the devel-
opment of vaccines [12,13]. The aim of this study was to
determine whether protective immunity could be
induced by immunisation with the Nc-Spain 1 H isolate
to prevent transplacental transmission and cerebral
neosporosis in a well-established BALB/c mouse model.
Furthermore, we measured the effect of various immu-
nising doses on this protection.
Materials and methods
Parasites and parasite antigens
Live N. caninum Nc-Spain 1 H [8] tachyzoites were used
for the immunisation, and tachyzoites from the Nc-Liv
isolate [14] were used for the heterologous challenge.
Nc-Liv tachyzoites were propagated under new culture
conditions using MARC-145 cells. This shift from Vero
cells to a new cell line was expected to homogenise the
cell passage in Nc-Liv [15]. Prior to the experiment, the
Nc-Liv and Nc-Spain 1 H tachyzoites were maintained
in vitro by continuous passage in MARC-145 cell mono-
layers, as previously described [15], to ensure healthy
and actively replicating parasites. In order to minimise
the occurrence of potential alterations in its biological
characteristics due to prolonged cell culture mainten-
ance, the experiments were performed using both iso-
lates subjected a limited number of culture passages in
the MARC-145 cells: Nc-Liv (passage no. 12) and Nc-
Spain 1 H (passage no. 9–15). The parasite viability and
numbers were determined by trypan blue exclusion, fol-
lowed by counting three aliquots in a Neubauer cham-
ber. The infection dose per mouse was adjusted withPBS to the required doses for immunisation or challenge
in a final volume of 200 μL per mouse. The parasites
were administered to the mice within 1 h of harvesting
from the tissue culture.
Nc-Liv tachyzoites that were used for antigens were
washed three times in sterile PBS (pH 7.4). Host cell
debris was separated by passing the mixture through a
25-gauge needle, followed by passage through PD-10
columns (Amersham Biosciences, Uppsala, Sweden).
Cell-free Nc-Liv tachyzoites were pelleted by centrifuga-
tion (600 × g, 10 min) and frozen at −80°C until use. To
obtain N. caninum soluble protein antigens, purified
tachyzoites were suspended in 1 mL of 10 mM Tris–
HCl containing 2 mM phenylmethylsulfonyl fluoride
(Sigma, St. Louis, MO, USA) and were disrupted by son-
ication (Sonifier 450, Branson Ultrasonic, Danbury, CT,
USA) in an ice bath. Cell debris and unlysed cells were
removed by centrifugation (10 000 × g, 20 min, 4°C). The
protein concentration of the supernatant was quantified
using the Micro BCA protein assay (Pierce, Rockford,
IL, USA), and the supernatant was aliquoted and frozen
at −80°C.
Mice and experimental design
Female BALB/c mice were purchased from a commercial
supplier (Harlan Interfauna Ibérica, Barcelona, Spain).
The mice were fed ad libitum in a controlled environ-
ment that included light and dark cycles (12-h light:12-h
darkness). All the protocols that involved animals were
approved by the Animal Research Committee of the
Complutense University, Madrid, Spain, in compliance
with the proceedings described in the Regulation of In-
ternal Regime for Animal Research Committee (pub-
lished at BOUC, no. 2, at 9 February 2006) and the EU
legislation (Council Directive 86/609/EEC).
The vaccine efficacy against congenital and cerebral
neosporosis was tested in two different experiments
using both pregnant and non-pregnant BALB/c mouse
models, as previously described [16-18]. Initially, to de-
termine the protective capacity of Nc-Spain 1 H, the
BALB/c female mice were immunised with 5 × 105 live
Nc-Spain 1 H tachyzoites (experiment no. 1). Subse-
quently, to examine the optimal immunising doses, the
mice were inoculated with ten-fold diluted Nc-Spain 1 H
tachyzoites (5 × 105 to 5 × 10) (experiment no. 2). Groups
of non-immunised/non-challenged and non-immunised/
challenged mice were included in each experiment to
ensure experiment reproducibility. In both experiments,
the mice were subcutaneously (s.c.) immunised twice at
three-week intervals with live Nc-Spain 1 H tachyzoites.
Three weeks after the booster immunisation, the BALB/
c mice were allowed to mate for 96 h following the syn-
chronisation of oestrus using the Whitten effect [19].
Day 0 of the pregnancy was defined as the first day that
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challenged with 2 × 106 Nc-Liv tachyzoites at mid-
gestation (between days 6 and 10 of gestation). Gestation
was evaluated by determining the weight of the mice on
day 18 after the first night mated. The pregnant animals
(≥ 25 g) were housed individually and were allowed to
carry their pregnancies to term. The pups were evaluated
daily from birth to day 30 postpartum (PP) for clinical
signs compatible with neosporosis [13,20,21]. Samples
from some progeny could not be collected due to canni-
balism by the dams. Female mice that did not become
pregnant were housed in groups of up to 5 mice. The
dams and non-pregnant mice were evaluated for cerebral
neosporosis during chronic infection until days 30 PP and
30 post-challenge, respectively [13,20,21], when all the
mice were sacrificed. Brains from the pups and adult mice
were removed aseptically and frozen at −80°C until
needed for DNA extraction.
Parameters evaluated for safety and efficacy
The safety of the various formulations was determined
by daily observation of the mice for adverse reactions
and by palpation for the presence of nodules at the in-
oculation sites on day 5 after the booster vaccination.
The presence of parasite DNA in the brain samples from
immunised mice was determined by PCR on day 5 after
the second immunisation and prior to challenge. Micro-
satellite analysis was used to discriminate the presence
of the challenge isolate (Nc-Liv) or the immunisation
isolate (Nc-Spain 1 H) in infected adult mice and pups
after challenge to verify immunisation isolate safety at
the administered doses.
To assess the protective efficacy against congenital neos-
porosis, litter size, neonatal mortality and vertical trans-
mission were determined. The litter size was defined as
the number of pups delivered per dam. Stillbirth was eval-
uated as the number of full-term dead pups at birth. The
neonates were examined daily for morbidity and mortality.
Neonatal mortality was defined as the number of dead
pups from birth to day 30 PP. Vertical transmission of N.
caninum was identified by the presence of parasite DNA
in the brains of pups. Protective efficacy against cerebral
neosporosis was analysed in the dams and mice that did
not become pregnant, by determining the presence of N.
caninum DNA in the brain. To determine the optimal
immunising doses, we calculated the protection rate
against congenital neosporosis; this protection rate was
defined as the proportion of neonates that remained
healthy until the end of the experiment, with no parasites
detected in their brain samples.
DNA extraction and nested-PCR
The Real Pure Extraction genomic-DNA kit (Durviz,
Valencia, Spain) was used to extract DNA from 20–40 mg of each host tissue and 107N. caninum tachy-
zoites, according to the manufacturer’s instructions. The
amounts of DNA were measured spectrophotometric-
ally, and the samples were diluted to a final concentra-
tion of 50 ng/μL. For the detection of parasite DNA, a
nested-PCR was performed against the internal tran-
scribed spacer (ITS1) region of N. caninum, using four
oligonucleotides as described by Buxton et al. [22].
Microsatellites analysis for isolate identification
DNA extracted from PCR-positive brains from adult
mice and pups was used as a template for the amplifica-
tion by nested PCR of four microsatellite markers MS4,
MS5, MS7 and MS21 previously described [23]. For
automated allele sizing, all reverse primers in the sec-
ondary PCR were fluorescently end-labelled. Amplified
products were prepared with HiDi formamide and Gene
Scan-500 (LIZ) Size Standards (Applied Biosystems, CA,
USA). The size of the fluorescent PCR product was
determined using a 48-capillary 3730 DNA analyser (Ap-
plied Biosystems, CA, USA) and analyzed with Gene-
MapperW V 3.5 Software [24].
Cytokine analysis
The cellular immune responses that were induced by
immunisation with 5 × 105 live Nc-Spain 1 H tachyzoites
(experiment no. 1) were determined prior to challenge.
On day 5 after the second immunisation, five random
animals from each group were sacrificed, and their
spleens were aseptically extracted and immediately pro-
cessed for splenocyte culture, as previously described
[20]. Briefly, the splenocytes were suspended in RPMI
1640 culture medium (Biowhittaker, Walkersville, Md.)
and were plated in 96-well plates at a concentration of
4 × 105 cells/well. The splenocytes were stimulated in
triplicate with concanavalin A (ConA) (5 μg/mL), N.
caninum tachyzoite soluble extract (10 μg/mL) or only
with media (control group). The cells were maintained
at 37°C with 5% CO2 for 72 h. Next, the culture super-
natants were collected by centrifugation and stored at
−80°C until cytokine analysis. A commercial ELISA kit
(BD Bioscience, San Jose, CA, USA) was used to quan-
tify IFN-γ, IL-4 and IL-10 cytokines in the supernatants,
according to the manufacturer’s instructions. The results
were expressed in pg/mL.
Humoral immune response
The humoral immune response induced by inoculation
with ten-fold diluted Nc-Spain 1 H tachyzoites (5 × 105
to 5 × 10) (experiment no. 2) was measured prior to
challenge. On day 5 after the second immunisation, five
random animals from each group were sacrificed, their
blood samples were collected by cardiac puncture, and
the recovered sera were aliquoted and cryopreserved at
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caninum-specific IgG1 and IgG2a isotypes were mea-
sured. Briefly, 96-well plates were coated with soluble N.
caninum tachyzoite antigens (0.5 μg in 100 μL/well), and
diluted murine serum samples (1:100) and anti-mouse
IgG2a or IgG1 antibody (1:5000; Southern Biotechnology,
USA) were used as described previously [16,25]. The
ELISA results were expressed as the average absorbance
values at 405 nm. The threshold value arbitrarily discrim-
inating between “positive” and “negative” (cut-off) was
defined by adding 3 standard deviations to the mean A405
value of sera from non-immunised/non-challenged mice.
The serum isotype balance was evaluated using the IgG1/
IgG2a ratio.
Data analysis
Differences in rates were evaluated using the Chi-
squared test or Fisher F-test. Postnatal mortality was
analysed using the Kaplan-Meier survival method and
the log-rank statistical test [26,27]. No significant differ-
ences were found in parasite detection frequency be-
tween the pregnant and non-pregnant mice in the brain
during the chronic infection phase. Consequently, data
collected from both groups of female mice were pooled
to improve the power of the statistical analysis. ELISA
data were analysed using one-way ANOVA followed by
Tukey’s multiple comparison test. A value of P<0.05 was
considered significant. The statistical analyses were per-
formed using the Statgraphics Plus v. 5.1 (StatPoint, Inc.,
Herndon, VA, USA) and the GraphPad Prism 5 v. 5.01
(San Diego, CA, USA) software.
The statistical probit method was used [28] to titrate
the protective effect of the immunising dose. This
method transformed the sigmoid dose–response curve
to a straight line, which was analysed using a specialised
linear regression model (probit link function), based on
the probability that an immunised animal experienced
“immunisation failure”. Immunisation failure was recorded
when an immunised animal developed severe clinical neos-
porosis, died, or was born congenitally infected following a
lethal heterologous Nc-Liv challenge. The analysis was con-
ducted using the statistical package SPSS Inc. (Chicago,
IL, USA).
Results
The Nc-Spain 1 H isolate was a safe live-vaccine candidate
Neither local or systemic reactions nor nodules at the
injection site were observed after each immunisation
prior to challenge. Furthermore, neither N. caninum-
related clinical signs nor parasite DNA in the brains of
the mice that were sacrificed before the challenge were
detected in any immunised group. Microsatellite analysis
was performed in PCR-positive tissues from adult mice
and pups in all the immunised/challenged groups. Thenon-immunised/challenged group served as control. In
all cases where analysis could be performed, results
showed that the profiles corresponded to the challenge
isolate Nc-Liv. The microsatellite profiles of the Nc-
Spain 1 H isolate corresponding to the immunisation
isolate were not detected.
Immunisation with 5 × 105 live Nc-Spain 1 H tachyzoites
limited vertical transmission and cerebral infection
The first experiment measured the capacity of the atte-
nuated Nc-Spain 1 H isolate to prevent the transplacen-
tal transmission of parasites to the progeny and to
prevent the establishment of chronic infections in the
brains of adult mice (Table 1). Upon challenge at mid-
gestation, a significantly longer median survival time was
observed in neonates from the mice that had been
immunised with 5 × 105 live tachyzoites (29 days) versus
the non-immunised/challenged mice (20 days) (P<0.001;
Log-rank test). The offspring from the immunised group
exhibited a significant reduction in their postnatal mor-
tality rate (2.4%, 1/41) compared with the mortality rate
that was observed in the non-immunised/challenged
group (84%, 42/50) (P<0.0001, Fisher’s exact test). The
vertical transmission was reduced from 89.1% (41/46) in
the non-immunised/challenged group to 2.3% (1/44) in
the immunised group (P<0.0001, Fisher’s exact test). No
significant differences in litter size were observed be-
tween the groups. When the vaccine efficacy against
cerebral infection was evaluated in the dams and non-
pregnant mice, all the immunised mice remained clinic-
ally healthy throughout the study, and no parasite DNA
was detected in their brain samples (P<0.0001, Fisher’s
exact test; immunised/challenged groups vs. non-immu-
nised/challenged group).
Cytokine response after immunisation with live Nc-Spain
1 H tachyzoites
IFN-γ, IL-10 and IL-4 cytokine production was deter-
mined in N. caninum-specific stimulated splenocytes
from the mice immunised with 5 × 105 live Nc-Spain 1 H
tachyzoites prior to challenge (Figure 1). Splenocytes
from immunised mice that were stimulated with N. cani-
num soluble antigen on day 5 after the booster secreted
high levels of IFN-γ in comparison with non-immunised
mice (P<0.001, one-way ANOVA). We also detected IL-
10 and IL-4 cytokines in immunised but not non-
immunised mice (P<0.001, one-way ANOVA).
Protection induced by live Nc-Spain 1 H tachyzoites was
not dose-dependent
To investigate the influence of the parasite dose on pro-
tection, the BALB/c mice were twice immunised with
10-fold increased parasite doses (5 × 105 to 5 × 10) and
then were challenged at mid-gestation (Table 1 and





Stillbirth Neonatal mortality Vertical transmission
Per pupsb Per littersc Per pupsd Per litterse Per pupsf Per littersg
5 × 105/challenged† 5.0 ± 2.2 4/45 (8.8%) 2/9 (22.2%) 1/41 (2.4%) 1/8 (12.5%) 1/44 (2.3%) 1/9 (11.1%) 0/16 (0%)
Non-immunised/challenged 5.2 ± 1.7 8/58 (13.8%) 5/11 (45.5%) 42/50 (84%) 11/11 (100%) 41/46 (89.1%) 11/11 (100%) 13/16 (81.25%)
Non-immunised/non-challenged 4.6 ± 1.4 0/37 (0%) 0/8 (0%) 0/37 (0%) 0/8 (0%) 0/37 (0%) 0/8 (0%) 0/17 (0%)
5× 105/challenged{ 4.6 ± 2.0 5/41 (12.2%) 4/9 (44.4%) 6/36 (16.6%) 2/9 (22.2%) 5/34 (14.7%) 4/9 (44.4%) 2/19 (10.5%)
5× 104/challenged 5.3 ± 1.3 8/79 (10.1%) 5/15 (33.3%) 8/71 (11.3%) 6/15 (40%) 9/75 (12%) 6/15 (40%) 1/24 (4.16%)
5× 103/challenged 5.8 ± 1.4 28/93 (30.1%) 11/16 (68.8%) 17/65 (26.1%) 7/15 (46.6%) 26/86 (30.2%) 7/15 (47%) 0/24 (0%)
5× 102/challenged 4.1 ± 1.5 4/41 (9.7%) 3/10 (30%) 7/37 (18.9%) 6/10 (60%) 14/41 (34.1%) 5/10 (50%) 1/26 (3.8%)
5× 10/challenged 4.4 ± 1.9 14/44 (31.8%) 5/10 (50%) 2/30 (6.6%) 2/9 (22.2%) 2/37 (5.4%) 2/9 (22.2%) 2/25 (8%)
Non-immunised/challenged 5.0 ± 1.7 25/70 (35.7%) 8/14 (57.1%) 38/45 (84.4%) 13/13 (100%) 37/51 (72.6%) 13/13 (100%) 17/24 (70.8%)
Non-immunised/non-challenged 5.3 ± 1.6 3/64 (4.7%) 3/12 (25%) 0/61 (0%) 0/12 (0%) 0/64 (0%) 0/12 (0%) 0/24 (0%)
† Experiment no. 1. Mice were randomly allocated in groups of 21–22 mice in experiment no. 1.
{ Experiment no. 2. The number of mice per group in experiment no. 2 was expanded to 29–31 mice to improve the statistical power by increasing the number.
of pregnant mice per group.
a Average ± SD.
b No. of stillborns/no. of total pups born in the group (percentage).
c No. of litters with at least one stillborn/no. of litters in the group (percentage).
d No. of pups dead from birth to 30 days PP/no. of pups born alive (percentage).
e No. of litters with at least one pup dead from birth to 30 days PP/no. of litters in the group (percentage).
f No. of nested PCR-positive pups/no. of analysed pups (percentage).
g No. of litters with at least one nested PCR-positive pup/no. of analysed litters (percentage).
h No. of nested PCR-positive adult mice/no. of analysed adult mice in the group at the chronic infection phase (percentage).
Figure 1 Cytokine production following stimulation with
soluble N. caninum antigen in mice twice immunised with
5× 105 live tachyzoites of Nc-Spain 1 H on day 5 after booster.
Bars represent the average amount of IFN-γ, IL-4 and IL-10 expressed
in pg/mL, and error bars indicate the standard error of the mean
(SEM) for each group.
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group in experiment no. 1 and the highest dose group in
experiment no. 2 did not reveal any significant differ-
ences. Similarly, no significant differences were observed
between non-immunised/challenged groups in either ex-
periment, indicating minimal variations regarding the
immunising and challenging preparations used for differ-
ent experiments. All the immunised groups exhibited
more than 60% protection against congenital infection.
These protection rates were significantly higher com-
pared with the 17% protection in the non-immunised/
challenged group (Table 1; P<0.0001, χ2). Interestingly,
the mice that were immunised with the lowest dose
(5 × 10) showed the highest protection rate (86%). Con-
cerning the dose–response relationship evaluated by the
probit method, no significant differences between the
probit values from the immunised groups were detected
(Figure 3; P= 0.848, probit). However, although no differ-
ences in the protection rates were detected, a weak trend
toward a dose-dependent increase in protection was
observed among the groups that were immunised with
doses ranging from 5× 102 to 5 × 105 live tachyzoites.
Regarding the protection against cerebral infection in
adult mouse, a significant reduction in the presence of
parasite DNA in the brain samples was detected in all
the immunised groups when compared to the non-
immunised/challenged group (Table 1; P<0.0001, χ2).Antibody response following immunisation with live
Nc-Spain 1 H tachyzoites
To determine the association between the pre-challenge
antibody response and the immunising dose, we further
determined which IgG antibody isotypes were increased.
The mice that were twice immunised with 5 × 105,
5 × 104 and 5 × 103 tachyzoites exhibited the highest
levels of IgG1 (Figure 4a; P<0.0001, one-way ANOVA;
Figure 2 Kaplan–Meier survival curves for the neonates born from dams that were twice immunised with various doses of live
Nc-Spain 1 H tachyzoites (5 × 105-5 × 10). The curves present the percent survival as the proportion of all individuals over a period of 30 days
PP. Vertical steps downward correspond to the days PP in which a death was observed and symbols indicate censored observations.
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vs. 5 × 104 and 5 × 103, Tukey’s) and IgG2a (Figure 4a;
P<0.0001, one-way ANOVA; 5 × 105, 5 × 104 and 5 × 103
vs. 5 × 10, Tukey’s). However, when the ratio IgG1/IgG2a
was evaluated the groups that were inoculated with the
lowest immunising doses induced a more polarised
IgG2a response (IgG1/IgG2a ratios < 1) (Figure 4b;
P<0.0001, one-way ANOVA; 5 × 105 and 5 × 104 vs.Figure 3 The probability of protection against congenital
neosporosis, expressed in probit values that are plotted
against the log10 immunising doses of Nc-Spain 1 H
tachyzoites in the dose-protection study. The fitting line
represents a probit link function that estimates the expected
probabilities of protection after immunisation with various doses of
live Nc-Spain 1 H tachyzoites (log10). The percentages represent the
protection rate against congenital neosporosis (no. of pups that
remained healthy with no parasites detected in the samples until
the end of the experiment/no. of analysed pups).5 × 102 and 5 × 10, Tukey’s). These results indicate that
low immunising doses of Nc-Spain1H promoted an
IgG2a-biased response, whereas high parasite doses
induced an IgG1-biased response.
Discussion
Vaccines provide green solutions to control disease be-
cause they are sustainable and reduce the reliance on
pharmacological drugs and pesticides [2]. Live vaccines
have been highly successful against protozoan parasites
such as Toxoplasma gondii, in which vaccination with
the live attenuated S48 strain prevents abortions in ewes
[29]. In fact, ToxovaxW is currently the only commercial
vaccine for toxoplasmosis worldwide. In bovine neos-
porosis, one of the approaches is to identify isolates that
are attenuated and can be used for live vaccine develop-
ment. The naturally attenuated Nc-Nowra strain of N.
caninum, which was isolated from an infected calf in
Australia, has been previously tested as a potential live-
vaccine candidate in an experimental mice model [30]
and a pregnant-bovine model [31], inducing a reduction
in transplacental transmission and protection against
foetal death, respectively. In spite of these promising
protective results, it is currently unknown whether this
isolate of N. caninum is responsible for foetal loss or is
vertically transmitted to progeny in cattle [32]. This fact
might be a major safety concern that would undermine
the live-vaccine approach. Furthermore, mice that were
immunised with different attenuated parasites similarly
showed a reduction or completely prevention of brain
pathology after challenging with virulent N. caninum
parasites [3-5,33].
The naturally attenuated Nc-Spain 1 H isolate was
selected to test its safety and efficacy against Neospora
infection for the following biological characteristics: it
displayed reduced virulence and did not show detectable
persistence in mouse or bovine models [8,11]. Although
Figure 4 Panel A. ELISA using anti-N.caninum IgG1 and IgG2a from the BALB/c mice that were immunised with various doses (5 × 105-
5 × 10) of Nc-Spain 1 H at day 5 after booster (panel A). The bars represent the optical density (OD) at 405 nm, and the error bars indicate
the SEM for each group. Positive cut-offs were established in ELISA for IgG1 detection at ≥ 0.132 and in ELISA for IgG2a detection at ≥ 0.131.
A total of 5 mice prior to challenge were included in the analysis. Panel B. Bars represent the average of anti-N. caninum IgG1:IgG2a isotype
ratios from the BALB/c mice that were immunised with various doses (5 × 105-5 × 10) of Nc-Spain 1 H at day 5 after booster. Error bars represent
the ± SEM. The discontinuous line marks identical IgG1 and IgG2a levels (IgG1:IgG2a= 1).
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tenuation are still unknown, recent studies comparing
the tachyzoite proteome of different N. caninum isolates
demonstrated variations in expression levels and a
modulation of proteins involved in invasion and prolif-
eration processes between Nc-Spain 1 H and the virulent
Nc-Liv and Nc-Spain 7 isolates [34]. In this sense,
reduced expression of some proteins involved in inva-
sion and proliferation processes such as NcNTPase,
microneme protein NcMIC1, and NcROP40 proteins
was observed in Nc-Spain1H isolate in comparison with
the two virulent isolates. This could explain the reduced
growth displayed by the Nc-Spain 1 H isolate in vitro
and its attenuated virulence in mice and bovines,
supporting the premise of its suitability as a vaccine
candidate.
Therefore, the present study determined the vaccine
efficacy and safety of this naturally attenuated N. cani-
num isolate using well-established mouse models of
cerebral and congenital neosporosis [16-18]. The preg-
nant mouse model provides a convenient tool for testing
the efficacy of vaccines against the transmission of the
parasite to progeny because there is a high transmission
rate of N. caninum to the offspring after the inoculation
of dams with a virulent isolate at the second trimester of
gestation [17,18]. Immunisation with 5 × 105 live Nc-
Spain 1 H tachyzoites conferred excellent protection
against heterologous challenge with Nc-Liv tachyzoites,
demonstrating reduced neonatal mortality and vertical
transmission rates, as well as high protection against
cerebral infection in adult mice. Moreover, immunisa-
tion with this dose of live parasites elicited a protective
immune response characterised by strong IFN-γ induc-
tion. It is widely reported that IFN-γ is one of the most
critical cytokines, mediating host protection against the
N. caninum infection by limiting parasite growth
[35-37]. However, a suitable cytokine production ofcellular and humoral immune responses may have an
important role for the control of the N. caninum infec-
tion. Thus, the increased IL-4 and IL-10 levels might
have been produced to restrain the inflammatory re-
sponse and restore a balance in the immune response
[38,39]. Our results on protection agree with several
studies in which protective immunity against murine
neosporosis was induced in mice using different live vac-
cine strategies, such as live tachyzoites attenuated by
prolonged in vitro culture [40], temperature-sensitive
mutant isolates of N. caninum [3], sub-lethal doses of
live virulent isolates [41] and transgenic N. caninum
strains [42]. However, inoculation with virulent parasites
produced more severe pathology and persistence com-
pared to mice inoculated with attenuated parasites
[40,42], suggesting problems related to safety and high-
lighting the importance of parasite attenuation approach
development. Differentiating between isolates used for
immunising and challenging is essential for studying live
attenuated vaccine safety. In this sense, microsatellite
analysis has proven to be a useful tool for differentiating
Neospora isolates in vaccination assays [42,43]. Regard-
ing the safety of the Nc-Spain 1 H isolate, no parasite
DNA was detected in the brains of immunised mice
prior to challenge. After challenge, microsatellite analysis
demonstrated that the parasite DNA detected in pups
and adult mice corresponded to the challenge isolate
Nc-Liv, indicating that Nc-Spain 1 H isolate was not
transmitted to the offspring and was unable to establish
a detectable cerebral infection. Taken together, these
results demonstrate that inoculation with live attenuated
parasites is safe and generates a protective immune re-
sponse against Neospora, which suggests that the Nc-
Spain 1 H isolate is a suitable live vaccine candidate.
Having established that immunisation with 5 × 105 live
Nc-Spain 1 H tachyzoites induced protection, we next
addressed the effects of various doses, which would be
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obstacles during the commercial manufacture of a live
vaccine are the short shelf life of viable parasites and the
safety of the vaccine itself. Here, no differences were
observed among the groups that were immunised with
different doses, showing that even at low doses high pro-
tection against congenital neosporosis was induced. The
present study provides encouraging results regarding the
possibility of reducing the administered dose of live Nc-
Spain 1 H tachyzoites. However, care must be taken
when extrapolating from the mouse data, and the
vaccine efficacy must be confirmed in the target species.
We also observed that the parasite dose appears to
modulate immune responses. The mice that were admi-
nistered the higher immunising doses predominantly
produced IgG1, in contrast, low immunising doses of
Nc-Spain1H promoted an IgG2a response. In other
intracellular protozoan parasites, such as Leishmania,
studies have provided evidence of the dose-dependent
character of the acquired resistance that affects the Th1/
Th2 nature of the immune response [44-46]. Some
reports also suggest that low doses of parasites promote
a Th1 response, whereas high parasite doses induce a
Th2 response; in contrast, other studies suggest the op-
posite [45-47]. In a previous N. caninum study, Lundén
et al. [41] demonstrated that the immunisation with a
relatively virulent isolate at different subclinical doses of
infection (104 and 106 tachyzoites) induced protective
immunity in BALB/c mice, even though different anti-
body profiles were detected. Specifically, in mice given
the highest number of parasites, the levels of IgG1 and
IgG2a were equally high, while mice inoculated with the
lower dose had higher IgG2a than IgG1 titres. Due to
the intracellular nature of the N. caninum infection, the
predicted protective immune response would be pre-
dominantly a type-1 (Th1) cell-mediated immune re-
sponse dominated by the production of IFN-γ, IL-12 and
IgG2a antibodies [35,48]. However, it has also been sug-
gested that a balanced Th1–Th2 response is required to
limit a damaging host immune response. Although the
detection of IgG1 and IgG2a subclasses is a non-direct
marker of Th1/Th2-type immune modulation, the anti-
body profiles observed here may indicate the induction
of different immune responses. The inoculation of a low
number of parasites may result in the internalisation
of most of the tachyzoites inside the early antigen-
presenting cells, enhancing an effective cell-mediated
immunity. On the contrary, after the inoculation of a
high parasite dose, some tachyzoites may remain extra-
cellular, eliciting a humoral immune response, which is
adequate to control the extracellular parasites. Moreover,
antibodies would block the invasion of the parasites into
host cells, similar to what has been observed in other
protozoan parasites [49,50]. Further studies are neededto investigate the mechanisms by which the parasite
dose modulates the protective immune response.
In this paper, we report that the immunisation of mice
with naturally attenuated tachyzoites of the Nc-Spain
1 H isolate induced a protective immunity, which was
able to efficiently control both congenital and cerebral
neosporosis. All the immunising doses conferred a de-
gree of protection against the vertical transmission of N.
caninum, and this protective efficacy was not dose-
dependent. These findings show that formulations con-
taining low parasite doses of Nc-Spain 1 H isolate could
be a practical approach because it may favour the com-
mercial manufacture of a live vaccine. Additionally, a
critical component in designing effective vaccines is an
understanding of the mechanisms by which the immune
system is able to protect the host. Further studies should
be conducted to address the duration of protection and
the immunological mechanisms that are involved in pro-
tective immunity.
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